NCT05210738

Brief Summary

The aim is to compare outcomes of two different procedures to prevent occult stress urinary incontinence (SUI) in patients who are having pelvic organ prolapse surgeries

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 27, 2022

Completed
Last Updated

January 27, 2022

Status Verified

January 1, 2022

Enrollment Period

2.4 years

First QC Date

January 14, 2022

Last Update Submit

January 14, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Urinary Distress Inventory, Short Form (UDI-6)

    one year after surgery

  • Incontinence Impact Questionnaire, Short Form (IIQ-7)

    one year after surgery

  • Voiding diary

    one year after surgery

Secondary Outcomes (1)

  • The rate of complications in both groups which includes adverse events, rate of urine retention with prolonged catheterization, and UTI.

    one year after surgery

Study Arms (2)

Single incision sling group

The patient will receive Altis mini-incision sling for treatment of occult SUI

Device: Single incision sling

Urethral bulking group

The patient will receive Bulkamid urethral bulking agent for treatment of SUI

Drug: Bulkamid bulking agent

Interventions

Single incision sling is used to treat occult SUI

Single incision sling group

Urethral bulking by Bulkamid is used to treat occult SUI

Urethral bulking group

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with advanced prolapse and preoperative evaluation showed occult stress incontinence

You may qualify if:

  • Females who are 18 years or old who were scheduled to either urethral bulking (Bulkamid) or single-incision sling (Altis sling) to address occult SUI with prolapse surgery. All patients reported no history of SUI preoperatively and during office physical exam, positive SUI was demonstrated during prolapse reduction.
  • Females who are 18 years or old who didn't have occult stress incontinence before their prolapse surgery and didn't receive any stress incontinence surgery during their prolapse surgery during the same period will be included as a control group.
  • English speaking patients.

You may not qualify if:

  • Patients who had either single-incision sling or urethral bulking with documented preoperative history of stress incontinence. Patients with a history of previous surgery for SUI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Christ Hospital

Cincinnati, Ohio, 45219, United States

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ahmed Abdelaziz

    The Christ Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 14, 2022

First Posted

January 27, 2022

Study Start

January 1, 2019

Primary Completion

June 1, 2021

Study Completion

June 1, 2021

Last Updated

January 27, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations